EHA-2024-poster-AFM28_final
Loading viewer...
presentation
Format: PDF presentation
This document presents research on AFM28, a bispecific innate cell engager targeting AML, showcasing its anti-tumor activity and potential for long-term remissions.
Loading viewer...
presentation
Format: PDF presentation
This document presents research on AFM28, a bispecific innate cell engager targeting AML, showcasing its anti-tumor activity and potential for long-term remissions.
presentation
presentation
Gladstone Investment
presentation
Achillion Pharmaceuticals
presentation
Grupo Sura
presentation
BMW
